Publications by authors named "Simon H Bridge"

Claim this Profile
A
Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?
Simon H Bridge, Sabrina Pagano, John K Lodge, Isaac T Shawa, Paula Marin-Crespo

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The core phageome and its interrelationship with preterm human milk lipids.
Wen C Yew, Gregory R Young, Andrew Nelson, William Cheung, Christopher J Stewart, Simon H Bridge

Cell Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis.
David A Sheridan, Isaac Thom Shawa, E Louise Thomas, Daniel J Felmlee, Simon H Bridge

Sci Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation and Application of a Novel Method to Identify Bacteriophages in Maternal Milk and Infant Stool Identifies Host-Phage Communities Within Preterm Infant Gut.
Gregory R Young, Wen C Yew, Andrew Nelson, Simon H Bridge, Janet E Berrington

Front Pediatr· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation.
Andrew Nelson, Christopher J Stewart, Nicholas A Kennedy, John K Lodge, Mark Tremelling, Simon H Bridge

J Crohns Colitis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the Elusive Hepatitis C Vaccine.
Stephen M Todryk, Margaret F Bassendine, Simon H Bridge

Vaccines (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
Margaret F Bassendine, Simon H Bridge, Geoffrey W McCaughan, Mark D Gorrell

J Diabetes· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review.
Margaret F Bassendine, Simon H Bridge

Eur J Rheumatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility.
Mohammad A Tariq, Francesca L C Everest, Lauren A Cowley, Rosanna Wright, Giles S Holt, Simon H Bridge

mSystems· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
Simon H Bridge, Sabrina Pagano, Meleri Jones, Graham R Foster, Dermot Neely

Hepatol Int· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism.
Simon H Bridge, David A Sheridan, Daniel J Felmlee, Mary M E Crossey, Fiona I Fenwick

J Hepatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A metagenomic approach to characterize temperate bacteriophage populations from Cystic Fibrosis and non-Cystic Fibrosis bronchiectasis patients.
Mohammad A Tariq, Francesca L C Everest, Lauren A Cowley, Anthony De Soyza, Giles S Holt, Simon H Bridge

Front Microbiol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial.
David A Sheridan, Simon H Bridge, Mary M E Crossey, Daniel J Felmlee, Fiona I Fenwick

Liver Int· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telaprevir or boceprevir based therapy for chronic hepatitis C infection: development of resistance-associated variants in treatment failure.
Malcolm J Macartney, Dianne Irish, Simon H Bridge, Ana Garcia-Diaz, Clare L Booth

Antiviral Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity.
David A Sheridan, Simon H Bridge, Daniel J Felmlee, Mary M E Crossey, Howard C Thomas

J Hepatol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV and the hepatic lipid pathway as a potential treatment target.
Margaret F Bassendine, David A Sheridan, Daniel J Felmlee, Simon H Bridge, Geoffrey L Toms

J Hepatol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.
Simon H Bridge, Sally A Sharpe, Mike J Dennis, Stuart D Dowall, Brian Getty

Virol J· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection.
Simon H Bridge, David A Sheridan, Daniel J Felmlee, Søren U Nielsen, Howard C Thomas

Gut· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles.
Daniel J Felmlee, David A Sheridan, Simon H Bridge, Søren U Nielsen, Ross W Milne

Gastroenterology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis